Skip to main content

Table 2 Association of CK 5/6 expression with clinicopathologic features of bladder cancer

From: Cytokeratin 5/6 expression in bladder cancer: association with clinicopathologic parameters and prognosis

 

CK 5/6 n (%)

P value

Positive

Negative

Focal positive

Total

Gender

 Male

8 (100)

77 (75.5)

8 (47.1)

93 (73.2)

0.014

 Female

0 (0)

25 (24.5)

9 (52.9)

34 (26.8)

 Total

8

102

17

127

 

Age group

 ≤ 25 years

0 (0)

1 (1)

0 (0)

1 (0.8)

0.613

 26–50 years

2 (25)

26 (25.5)

2 (11.8)

30 (23.6)

 > 50 years

6 (75)

75 (73.5)

15 (88.2)

96 (75.6)

 Total

8

102

17

127

 

Tissue type

 Transurethral resection

6 (75)

99 (97.1)

17 (100)

122 (96.1)

0.049

 Radical cystectomy

2 (25)

3 (2.9)

0 (0)

5 (3.9)

 Total

8

102

17

127

 

Tumor grade

 Low grade

0 (0)

59 (57.8)

5 (29.4)

64 (50.4)

0.000

 High grade

8 (100)

43 (42.2)

12 (70.6)

63 (49.6)

Total

8

102

17

127

 

Lamina propria invasion

 Present

5 (62.5)

31 (30.4)

3 (17.6)

39 (30.7)

0.081

 Absent

3 (37.5)

71 (69.6)

14 (82.4)

88 (69.3)

 Total

8

102

17

127

 

Deep muscle invasion

 Present

5 (62.5)

19 (18.6)

2 (11.8)

26 (20.5)

0.049

 Absent

1 (12.5)

47 (46.1)

10 (58.8)

58 (45.7)

 Can’t assessed

2 (25)

36 (35.3)

5 (29.4)

43 (33.9)

 Total

8

102

17

127

 

Recurrence (n = 54)

 Yes

2 (50)

18 (40)

2 (40)

22 (40.7)

1.000

 No

2 (50)

27 (60)

3 (60)

32 (59.3)

 Total

4

45

5

54

 

Survival status (n = 54)

 Alive

3 (75)

39 (86.7)

5 (100)

47 (87)

0.514

 Expired

1 (25)

6 (13.3)

0 (0)

7 (13)

 Total

4

45

5

54

 
  1. Fisher exact test applied
  2. P ≤ 0.05, considered as significant